• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TIP5 使前列腺腔细胞对 -loss 介导的致癌转化敏感。

TIP5 primes prostate luminal cells for the oncogenic transformation mediated by -loss.

机构信息

Department of Molecular Mechanisms of Disease, DMMD, University of Zürich, CH-8057 Zürich, Switzerland.

Molecular Life Science Program, Life Science Zürich Graduate School, University of Zürich, CH-8057 Zürich, Switzerland.

出版信息

Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3637-3647. doi: 10.1073/pnas.1911673117. Epub 2020 Feb 5.

DOI:10.1073/pnas.1911673117
PMID:32024754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7035629/
Abstract

Prostate cancer (PCa) is the second leading cause of cancer death in men. Its clinical and molecular heterogeneities and the lack of in vitro models outline the complexity of PCa in the clinical and research settings. We established an in vitro mouse PCa model based on organoid technology that takes into account the cell of origin and the order of events. Primary PCa with deletion of the tumor suppressor gene (-del) can be modeled through down-regulation in mouse organoids. We used this system to elucidate the contribution of TIP5 in PCa initiation, a chromatin regulator that is implicated in aggressive PCa. High TIP5 expression correlates with primary -del PCa and this combination strongly associates with reduced prostate-specific antigen (PSA) recurrence-free survival. TIP5 is critical for the initiation of PCa of luminal origin mediated by -loss whereas it is dispensable once -loss mediated transformation is established. Cross-species analyses revealed a gene signature that identified a group of aggressive primary PCas characterized by -del, high-TIP5 expression, and a TIP5-regulated gene expression profile. The results highlight the modeling of PCa with organoids as a powerful tool to elucidate the role of genetic alterations found in recent studies in their time orders and cells of origin, thereby providing further optimization for tumor stratification to improve the clinical management of PCa.

摘要

前列腺癌(PCa)是男性癌症死亡的第二大主要原因。其临床和分子异质性以及缺乏体外模型突出了 PCa 在临床和研究环境中的复杂性。我们基于类器官技术建立了一种体外小鼠 PCa 模型,该模型考虑了细胞起源和事件的顺序。通过下调小鼠类器官中的肿瘤抑制基因缺失(-del)可以模拟原发性 PCa。我们使用该系统阐明了染色质调节剂 TIP5 在 PCa 起始中的作用,该调节剂与侵袭性 PCa 有关。高 TIP5 表达与原发性 -del PCa 相关,并且这种组合与前列腺特异性抗原(PSA)无复发生存率降低密切相关。TIP5 对于由 -loss 介导的管腔起源的 PCa 起始至关重要,而一旦 -loss 介导的转化建立,TIP5 就是可有可无的。种间分析揭示了一个基因特征,该特征鉴定了一组具有以下特征的侵袭性原发性 PCa:-del、高 TIP5 表达和 TIP5 调节的基因表达谱。结果强调了使用类器官对 PCa 进行建模,这是一种强大的工具,可以阐明最近研究中发现的遗传改变在其时间顺序和细胞起源中的作用,从而进一步优化肿瘤分层以改善 PCa 的临床管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/e2b2315acb18/pnas.1911673117fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/af0a08a791f4/pnas.1911673117fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/79360aba9427/pnas.1911673117fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/304c04cab801/pnas.1911673117fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/87a65b5ce78b/pnas.1911673117fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/83151c2a4f92/pnas.1911673117fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/e2b2315acb18/pnas.1911673117fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/af0a08a791f4/pnas.1911673117fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/79360aba9427/pnas.1911673117fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/304c04cab801/pnas.1911673117fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/87a65b5ce78b/pnas.1911673117fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/83151c2a4f92/pnas.1911673117fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e9/7035629/e2b2315acb18/pnas.1911673117fig06.jpg

相似文献

1
TIP5 primes prostate luminal cells for the oncogenic transformation mediated by -loss.TIP5 使前列腺腔细胞对 -loss 介导的致癌转化敏感。
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3637-3647. doi: 10.1073/pnas.1911673117. Epub 2020 Feb 5.
2
NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.NFATc1促进前列腺肿瘤发生并克服PTEN缺失诱导的衰老。
Oncogene. 2016 Jun 23;35(25):3282-92. doi: 10.1038/onc.2015.389. Epub 2015 Oct 19.
3
PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome.PTEN 缺失与血红素加氧酶-1 过表达协同促进前列腺癌进展,并与不良临床结局相关。
J Pathol. 2011 May;224(1):90-100. doi: 10.1002/path.2855. Epub 2011 Mar 7.
4
BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells.BAZ2A 通过 H3K14ac 标记的增强子介导的抑制作用促进前列腺癌干细胞。
EMBO Rep. 2021 Nov 4;22(11):e53014. doi: 10.15252/embr.202153014. Epub 2021 Aug 17.
5
RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.RUNX2 过表达和 PTEN 杂合性缺失协同促进 CXCR7 的表达和细胞转运、AKT 的过度激活以及前列腺肿瘤的发生。
Theranostics. 2019 May 24;9(12):3459-3475. doi: 10.7150/thno.33292. eCollection 2019.
6
MEX3D is an oncogenic driver in prostate cancer.MEX3D 是前列腺癌中的致癌驱动基因。
Prostate. 2021 Nov;81(15):1202-1213. doi: 10.1002/pros.24216. Epub 2021 Aug 29.
7
Transcriptional landscape of PTEN loss in primary prostate cancer.原发性前列腺癌中 PTEN 缺失的转录组景观。
BMC Cancer. 2021 Jul 26;21(1):856. doi: 10.1186/s12885-021-08593-y.
8
Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.在类器官转化试验中,前列腺上皮细胞的起源决定癌症分化状态。
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4482-7. doi: 10.1073/pnas.1603645113. Epub 2016 Apr 4.
9
Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer.染色质重塑 ATP 酶 BRG1 和 PTEN 在前列腺癌中是合成致死的。
J Clin Invest. 2019 Feb 1;129(2):759-773. doi: 10.1172/JCI123557. Epub 2019 Jan 14.
10
Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.Klf5基因缺失通过多种致癌信号通路促进由Pten基因缺失引发的管腔型小鼠前列腺肿瘤。
Neoplasia. 2014 Nov 20;16(11):883-99. doi: 10.1016/j.neo.2014.09.006. eCollection 2014 Nov.

引用本文的文献

1
Endocrine cancer organoids in basic and translational medical research.基础与转化医学研究中的内分泌癌类器官
Sci China Life Sci. 2025 Jun 5. doi: 10.1007/s11427-024-2888-8.
2
Transcription Activator FgDDT Interacts With FgISW1 to Regulate Fungal Development and Pathogenicity in the Global Pathogen Fusarium graminearum.转录激活因子FgDDT与FgISW1相互作用以调控全球病原菌禾谷镰刀菌的真菌发育和致病性。
Mol Plant Pathol. 2025 Apr;26(4):e70076. doi: 10.1111/mpp.70076.
3
Discovery of First-in-Class BAZ2A/B and BAZ2B-Selective Degraders.

本文引用的文献

1
Genomic correlates of clinical outcome in advanced prostate cancer.晚期前列腺癌的临床结局的基因组相关性。
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436. doi: 10.1073/pnas.1902651116. Epub 2019 May 6.
2
The Proteogenomic Landscape of Curable Prostate Cancer.可治愈前列腺癌的蛋白质基因组全景分析
Cancer Cell. 2019 Mar 18;35(3):414-427.e6. doi: 10.1016/j.ccell.2019.02.005.
3
Cancer statistics, 2019.癌症统计数据,2019 年。
一流的BAZ2A/B和BAZ2B选择性降解剂的发现。
ACS Med Chem Lett. 2025 Jan 7;16(2):234-240. doi: 10.1021/acsmedchemlett.4c00334. eCollection 2025 Feb 13.
4
Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer.泛癌和多组学分析揭示了BAZ2A在肝癌中的诊断和预后价值。
Sci Rep. 2024 Mar 4;14(1):5228. doi: 10.1038/s41598-024-56073-7.
5
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research.类器官:前列腺癌研究中的新兴精准医学模型。
Int J Mol Sci. 2024 Jan 16;25(2):1093. doi: 10.3390/ijms25021093.
6
BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer.BAZ2A-RNA 介导与 TOP2A 和 KDM1A 的关联,抑制前列腺癌相关基因。
Life Sci Alliance. 2023 Apr 25;6(7). doi: 10.26508/lsa.202301950. Print 2023 Jul.
7
Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states.单细胞分析人类原发性前列腺癌揭示了肿瘤相关上皮细胞状态的异质性。
Nat Commun. 2022 Jan 10;13(1):141. doi: 10.1038/s41467-021-27322-4.
8
The emerging role of ISWI chromatin remodeling complexes in cancer.ISWI 染色质重塑复合物在癌症中的新兴作用。
J Exp Clin Cancer Res. 2021 Nov 4;40(1):346. doi: 10.1186/s13046-021-02151-x.
9
Application of Organoid Models in Prostate Cancer Research.类器官模型在前列腺癌研究中的应用。
Front Oncol. 2021 Sep 27;11:736431. doi: 10.3389/fonc.2021.736431. eCollection 2021.
10
BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells.BAZ2A 通过 H3K14ac 标记的增强子介导的抑制作用促进前列腺癌干细胞。
EMBO Rep. 2021 Nov 4;22(11):e53014. doi: 10.15252/embr.202153014. Epub 2021 Aug 17.
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
4
Prostate Luminal Progenitor Cells in Development and Cancer.发育和癌症中的前列腺管腔祖细胞
Trends Cancer. 2018 Nov;4(11):769-783. doi: 10.1016/j.trecan.2018.09.003. Epub 2018 Oct 1.
5
Prostate Stem Cells and Cancer Stem Cells.前列腺干细胞和癌症干细胞。
Cold Spring Harb Perspect Med. 2019 Jun 3;9(6):a030395. doi: 10.1101/cshperspect.a030395.
6
Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.全基因组扫描鉴定 AOX1 在前列腺癌生存中的作用。
Eur Urol. 2018 Dec;74(6):710-719. doi: 10.1016/j.eururo.2018.06.021. Epub 2018 Jul 7.
7
Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer.MCM10的过表达促进前列腺癌细胞增殖并预示不良预后。
Prostate. 2018 Dec;78(16):1299-1310. doi: 10.1002/pros.23703. Epub 2018 Aug 10.
8
Patient derived organoids to model rare prostate cancer phenotypes.基于患者来源的类器官模型来研究罕见前列腺癌表型。
Nat Commun. 2018 Jun 19;9(1):2404. doi: 10.1038/s41467-018-04495-z.
9
Epigenetic Priming in Cancer Initiation.癌症起始中的表观遗传预激发
Trends Cancer. 2018 Jun;4(6):408-417. doi: 10.1016/j.trecan.2018.04.007.
10
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.神经内分泌前列腺癌的长非编码 RNA 图谱及其临床意义。
Gigascience. 2018 Jun 1;7(6). doi: 10.1093/gigascience/giy050.